Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer R Cochran

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Neuro-Oncology|May 29, 2021
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca-Maria Marin, Kendra A Porath, Sonia Jain, et al.
Cancer Cell|January 23, 2026
IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline gliomaRaphaël Collot, Cristian Ruiz-Moreno, Celina Honhoff, et al.
Nature|May 15, 2024
Engineered CD47 protects T cells for enhanced antitumour immunitySean A Yamada-Hunter, Johanna Theruvath, Brianna J McIntosh, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
<i>De novo</i> design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8Anindya Roy, Lei Shi, Ashley Chang, et al.
Nature Communications|September 13, 2023
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8Anindya Roy, Lei Shi, Ashley Chang, et al.
Nature Medicine|January 14, 2022
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradicationJohanna Theruvath, Marie Menard, Benjamin A H Smith, et al.
IEEE Open Journal of Engineering in Medicine and Biology|February 28, 2024
Grand Challenges at the Interface of Engineering and MedicineShankar Subramaniam, Metin Akay, Mark A Anastasio, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Neuro-Oncology|May 29, 2021
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca-Maria Marin, Kendra A Porath, Sonia Jain, et al.
Cancer Cell|January 23, 2026
IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline gliomaRaphaël Collot, Cristian Ruiz-Moreno, Celina Honhoff, et al.
Nature|May 15, 2024
Engineered CD47 protects T cells for enhanced antitumour immunitySean A Yamada-Hunter, Johanna Theruvath, Brianna J McIntosh, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
<i>De novo</i> design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8Anindya Roy, Lei Shi, Ashley Chang, et al.
Nature Communications|September 13, 2023
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8Anindya Roy, Lei Shi, Ashley Chang, et al.
Nature Medicine|January 14, 2022
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradicationJohanna Theruvath, Marie Menard, Benjamin A H Smith, et al.
IEEE Open Journal of Engineering in Medicine and Biology|February 28, 2024
Grand Challenges at the Interface of Engineering and MedicineShankar Subramaniam, Metin Akay, Mark A Anastasio, et al.
Pageof 11